Cargando…

Real-life evaluation of histologic scores for Ulcerative Colitis in remission

BACKGROUND: Histological evaluation of ulcerative colitis (UC) patients has been debated ever since the first description of the disease and its role in follow-up has never been fully established. Recent evidence suggests an added benefit in accuracy when evaluating if the patient is in remission. U...

Descripción completa

Detalles Bibliográficos
Autores principales: Arkteg, Christian Børde, Wergeland Sørbye, Sveinung, Buhl Riis, Lene, Dalen, Stig Manfred, Florholmen, Jon, Goll, Rasmus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939352/
https://www.ncbi.nlm.nih.gov/pubmed/33684168
http://dx.doi.org/10.1371/journal.pone.0248224
_version_ 1783661734713622528
author Arkteg, Christian Børde
Wergeland Sørbye, Sveinung
Buhl Riis, Lene
Dalen, Stig Manfred
Florholmen, Jon
Goll, Rasmus
author_facet Arkteg, Christian Børde
Wergeland Sørbye, Sveinung
Buhl Riis, Lene
Dalen, Stig Manfred
Florholmen, Jon
Goll, Rasmus
author_sort Arkteg, Christian Børde
collection PubMed
description BACKGROUND: Histological evaluation of ulcerative colitis (UC) patients has been debated ever since the first description of the disease and its role in follow-up has never been fully established. Recent evidence suggests an added benefit in accuracy when evaluating if the patient is in remission. Unfortunately, there are several different histological indices, and it is difficult to compare outcomes where different scores are applied. Histopathological evaluation is prone to subjective biases, despite the use of indices. In addition, these indices are developed by expert IBD pathologist, but applied at large, by general pathologist. Therefore, we evaluated the three most applied histological indices for UC on samples from patients in remission to compare test qualities and estimate their usefulness to identify remission by both general and GI specialized pathologist. METHOD: Mucosal biopsies from 41 UC patients in clinical and endoscopic remission were collected as part of a larger study on UC. Three pathologists blinded to the patients’ clinical status evaluated them using Geboes score (GS), Nancy Index (NI) and Robarts Histopathological Index (RHI). We calculated the agreement between the pathologists using Inter-class correlation (ICC) and visualized it with ICC-plots and Bland-Altman plots. Association between clinical factors and histological category were analysed by Fisher’s exact test. RESULTS: The ICC value for GS, RHI and NI were 0.85, 0.73 and 0.70 respectively. The limits of agreement were ±6.1, ±4.0 and ±1.4, for GS, RHI and NI, respectively. Mayo endoscopic subgrade and UC clinical score did not show association with any histological scores. Despite clinical and endoscopic remission 7–35% of the patients displayed histological inflammation on a level classified as active disease, depending on the index and cut-off. CONCLUSION: A substantial amount of UC patients in clinical and endoscopic remission display inflammation on a histological level, but the ability to classify these patients accurately and consistently could be improved.
format Online
Article
Text
id pubmed-7939352
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-79393522021-03-18 Real-life evaluation of histologic scores for Ulcerative Colitis in remission Arkteg, Christian Børde Wergeland Sørbye, Sveinung Buhl Riis, Lene Dalen, Stig Manfred Florholmen, Jon Goll, Rasmus PLoS One Research Article BACKGROUND: Histological evaluation of ulcerative colitis (UC) patients has been debated ever since the first description of the disease and its role in follow-up has never been fully established. Recent evidence suggests an added benefit in accuracy when evaluating if the patient is in remission. Unfortunately, there are several different histological indices, and it is difficult to compare outcomes where different scores are applied. Histopathological evaluation is prone to subjective biases, despite the use of indices. In addition, these indices are developed by expert IBD pathologist, but applied at large, by general pathologist. Therefore, we evaluated the three most applied histological indices for UC on samples from patients in remission to compare test qualities and estimate their usefulness to identify remission by both general and GI specialized pathologist. METHOD: Mucosal biopsies from 41 UC patients in clinical and endoscopic remission were collected as part of a larger study on UC. Three pathologists blinded to the patients’ clinical status evaluated them using Geboes score (GS), Nancy Index (NI) and Robarts Histopathological Index (RHI). We calculated the agreement between the pathologists using Inter-class correlation (ICC) and visualized it with ICC-plots and Bland-Altman plots. Association between clinical factors and histological category were analysed by Fisher’s exact test. RESULTS: The ICC value for GS, RHI and NI were 0.85, 0.73 and 0.70 respectively. The limits of agreement were ±6.1, ±4.0 and ±1.4, for GS, RHI and NI, respectively. Mayo endoscopic subgrade and UC clinical score did not show association with any histological scores. Despite clinical and endoscopic remission 7–35% of the patients displayed histological inflammation on a level classified as active disease, depending on the index and cut-off. CONCLUSION: A substantial amount of UC patients in clinical and endoscopic remission display inflammation on a histological level, but the ability to classify these patients accurately and consistently could be improved. Public Library of Science 2021-03-08 /pmc/articles/PMC7939352/ /pubmed/33684168 http://dx.doi.org/10.1371/journal.pone.0248224 Text en © 2021 Arkteg et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Arkteg, Christian Børde
Wergeland Sørbye, Sveinung
Buhl Riis, Lene
Dalen, Stig Manfred
Florholmen, Jon
Goll, Rasmus
Real-life evaluation of histologic scores for Ulcerative Colitis in remission
title Real-life evaluation of histologic scores for Ulcerative Colitis in remission
title_full Real-life evaluation of histologic scores for Ulcerative Colitis in remission
title_fullStr Real-life evaluation of histologic scores for Ulcerative Colitis in remission
title_full_unstemmed Real-life evaluation of histologic scores for Ulcerative Colitis in remission
title_short Real-life evaluation of histologic scores for Ulcerative Colitis in remission
title_sort real-life evaluation of histologic scores for ulcerative colitis in remission
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939352/
https://www.ncbi.nlm.nih.gov/pubmed/33684168
http://dx.doi.org/10.1371/journal.pone.0248224
work_keys_str_mv AT arktegchristianbørde reallifeevaluationofhistologicscoresforulcerativecolitisinremission
AT wergelandsørbyesveinung reallifeevaluationofhistologicscoresforulcerativecolitisinremission
AT buhlriislene reallifeevaluationofhistologicscoresforulcerativecolitisinremission
AT dalenstigmanfred reallifeevaluationofhistologicscoresforulcerativecolitisinremission
AT florholmenjon reallifeevaluationofhistologicscoresforulcerativecolitisinremission
AT gollrasmus reallifeevaluationofhistologicscoresforulcerativecolitisinremission